Therapeutic Potential of Active Components from Acorus gramineus and Acorus tatarinowii in Neurological Disorders and Their Application in Korean Medicine

키워드

참고문헌 (99)

1. GBD 2016 Neurology Collaborators, "Global, regional, and national burden of neurological disorders, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016", Lancet Neurol, 18(5), pp.459~480 (2019)
2. Parés-Badell O, "Cost of disorders of the brain in Spain", PLoS One, 9(8), pp.e105471~ (2014)
3. Cheol Hyeong Park, "Phenolic Constituents of Acorus gramineus", Archives of Pharmacal Research, 34(8), pp.1289~1296 (2011), 대한약학회
4. Balakrishnan R, "Molecular mechanisms and therapeutic potential of α-and β-asarone in the treatment of neurological disorders", Antioxidants (Basel), 11(2), pp.281~ (2022)
5. Jakob-Roetne R, "Alzheimer’s disease : from pathology to therapeutic approaches", Angew Chem Int Ed Engl, 48(17), pp.3030~3059 (2009)
6. 김성윤, "알츠하이머 치매 약물치료의 현황과 미래", 신경정신의학, 57(1), pp.30~42 (2018), 대한신경정신의학회[DOI]
7. Chen XY, "Essential oil of Acorus tatarinowii schott ameliorates Aβ-induced toxicity in Caenorhabditis elegans through an autophagy pathway", Oxid Med Cell Longev, 2020, pp.3515609~ (2020)
8. Deng M, "β‑asarone modulates Beclin‑1, LC3and p62 expression to attenuate Aβ40 and Aβ42 levels in APP", PS1 transgenic mice with Alzheimer’s disease, 2020, pp.21(5), 2095~2102
9. Deng M, "β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP", PS1 transgenic mice by regulating Beclin-1-dependent autophagy, 2016, pp.1652, 188~194
10. Wei G, "β-Asarone inhibits neuronal apoptosis via the CaMKII", CREB, PS1mice, pp.J Alzheimers Dis, 2013[DOI]
11. Liang ZH, "Protective effects of components of the Chinese herb grassleaf sweetflag rhizome on PC12 cells incubated with amyloid-beta42", Neural Regen Res, 10(8), pp.1292~1297 (2015)
12. Li C, "Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12cells via JNK signaling and modulation of Bcl-2 family proteins", Eur J Pharmacol, 635(1-3), pp.96~102 (2010)
13. Geng Y, "Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats", Biol Pharm Bull, 33(5), pp.836~843 (2010)
14. Liu J, "Beta-asarone attenuates neuronal apoptosis induced by Beta amyloid in rat hippocampus", Yakugaku Zasshi, 130(5), pp.737~746 (2010)
15. Wang N, "β-asarone inhibits amyloid-β by promoting autophagy in a cell model of Alzheimer’s disease", Front Pharmacol, 10, pp.1529~ (2020)
16. Wang N, "The combination of β-asarone and icariin inhibits amyloid-β and reverses cognitive deficits by promoting mitophagy in models of Alzheimer’s disease", Oxid Med Cell Longev, 2021, pp.7158444~ (2021)
17. Chen Y, "β-Asarone prevents autophagy and synaptic loss by reducing ROCK expression in asenescence-accelerated prone 8 mice", Brain Res, 1552, pp.41~54 (2014)
18. Xue Z, "Beta-asarone attenuates amyloid beta-induced autophagy via Akt", mTOR pathway in PC12 cells, 2014, pp.741, 195~204
19. Chang W, "β-asarone prevents Aβ25-35-induced inflammatory responses and autophagy in SH-SY5Y cells : down expression Beclin-1, LC3B and up expression Bcl-2", Int J Clin Exp Med, 8(11), pp.20658~20663 (2015)
20. Yang Y, "Neuroprotective effects and mechanism of β-asarone against Aβ 1-42-induced injury in astrocytes", Evid Based Complement Alternat Med, 2017, pp.8516518~ (2017)
21. Cai Q, "Neurogenesis-promoting natural product α-asarone modulates morphological dynamics of activated microglia", Front Cell Neurosci, 10, pp.280~ (2016)
22. Limón ID, "Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloidbeta((25-35))", Neurosci Lett, 453(2), pp.98~103 (2009)
23. Saki G, "Effect of β-asarone in normal and β-amyloid-induced Alzheimeric rats", Arch Med Sci, 16(3), pp.699~706 (2020)
24. Meng M, "β-asarone ameliorates β-amyloid-induced neurotoxicity in PC12 cells by activating P13K", Akt, Front Pharmacol, pp.2021, 12[DOI]
25. Kumar P, "β-asarone restores hippocampal neurochemistry and improve cognitive functions in Aβ (1-42) infused rats", Alzheimer’s Dement, 15(7), pp.P1292~ (2019)
26. Liu SJ, "Neuroprotective effect of β-asarone against Alzheimer’s disease : regulation of synaptic plasticity by increased expression of SYP and GluR1", Drug Des Devel Ther, 10, pp.1461~1469 (2016)
27. Chen Y, "Alphaasarone improves cognitive function of aged rats by alleviating neuronal excitotoxicity via GABAA receptors", Neuropharmacology, 162, pp.107843~ (2020)
28. Cho J, "Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus", Life Sci, 71(5), pp.591~599 (2002)
29. Dong H, "Efficacy of tenuigenin and β-asarone as augmentations for memantine in the treatment of Alzheimer’s disease", Neuroreport, 29(3), pp.203~207 (2018)
30. Chang W, "Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer’s disease", Drug Des Devel Ther, 12, pp.455~462 (2018)
31. Li Z, "Cerebrovascular protection of β-asarone in Alzheimer’s disease rats : a behavioral, cerebral blood flow, biochemical and genic study", J Ethnopharmacol, 144(2), pp.305~312 (2012)
32. Ma Y, "The effect of acori graminei rhizoma and extract fractions on spatial memory and hippocampal neurogenesis in amyloid beta 1-42 injected mice", CNS Neurol Disord Drug Targets, 14(3), pp.411~420 (2015)
33. Mao J, "A herbal medicine for Alzheimer’s disease and its active constituents promote neural progenitor proliferation", Aging Cell, 14(5), pp.784~796 (2015)
34. Lam KYC, "Asarones from Acori Tatarinowii Rhizoma stimulate expression and secretion of neurotrophic factors in cultured astrocytes", Neurosci Lett, 707, pp.134308~ (2019)
35. Gao N, "Volatile oil from acorus gramineus ameliorates the injury neurons in the hippocampus of amyloid beta 1-42 injected mice", Anat Rec(Hoboken), 302(12), pp.2261~2270 (2019)
36. Bloem BR, "Parkinson’s disease", Lancet, 397(10291), pp.2284~2303 (2021)
37. Zhang S, "Neuroprotective effects of β-asarone against 6-hydroxy dopamine-induced Parkinsonism via JNK", Bcl-2, Mol Neurobiol, pp.2016, 53(1)[DOI]
38. Zhang QS, "Beta-asarone protects against MPTP-induced Parkinson’s disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression", Biomed Pharmacother, 83, pp.153~159 (2016)
39. Kim BW, "α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTPinduced behavioral deficits in a mouse model of Parkinson’s disease", Neuropharmacology, 97, pp.46~57 (2015)
40. Ning B, "β-asarone regulates ER stress and autophagy via inhibition of the PERK", CHOP, Beclin-1 pathway in 6-OHDA-induced parkinsonian rats, pp.Neurochem Res, 2019[DOI]
41. Ning B, "β-asarone inhibits IRE1", XBP1 endoplasmic reticulum stress pathway in 6-OHDAinduced parkinsonian rats, 2016, pp.41(8), 2097~2101
42. Huang L, "β-asarone increases MEF2D and TH levels and reduces α-synuclein level in 6-OHDA-induced rats via regulating the HSP70", MAPK, Beclin-1 pathway: chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression, pp.Behav Brain Res, 2016[DOI]
43. Jiang J, "Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine(MPTP)-induced mouse model of Parkinson’s disease", J Ethnopharmacol, 144(3), pp.506~513 (2012)
44. Liu H, "Effect and mechanism of beta asarone from Acorus tatarinowii Schott on neuron injury in rats with Parkinson’s disease", Indian J Pharm Sci, 84(2), pp.400~406 (2021)
45. Huang L, "Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa : a different mechanism from Madopar", Clin Exp Pharmacol Physiol, 41(9), pp.685~690 (2014)
46. Huang L, "β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson’s rat by enhancing dopa decarboxylase activity", Biomed Pharmacother, 94, pp.666~678 (2017)
47. Huang L, "β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain", Clin Exp Pharmacol Physiol, 43(6), pp.634~643 (2016)
48. Huang LP, "β-asarone and levodopa co-administration protects against 6-hydroxydopamine-induced damage in parkinsonian rat mesencephalon by regulating autophagy : down-expression Beclin-1 and light chain 3B and upexpression P62", Clin Exp Pharmacol Physiol, 42(3), pp.269~277 (2015)
49. Willner P, "The neurobiology of depression and antidepressant action", Neurosci Biobehav Rev, 37(10 Pt 1), pp.2331~2371 (2013)
50. Dong H, "β-asarone reverses chronic unpredictable mild stress-induced depression-like behavior and promotes hippocampal neurogenesis in rats", Molecules, 19(5), pp.5634~5649 (2014)
51. Dong H, "β-asarone relieves chronic unpredictable mild stress induced depression by regulating the extracellular signal-regulated kinase signaling pathway", Exp Ther Med, 18(5), pp.3767~3774 (2019)
52. Sun YR, "β-asarone from Acorus gramineus alleviates depression by modulating MKP-1", Genet Mol Res, 14(2), pp.4495~4504 (2015)
53. Chellian R, "Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice : evidence for the modulation of hippocampal pCREB levels during nicotinewithdrawal", Eur J Pharmacol, 818, pp.10~16 (2018)
54. Han P, "Antidepressant-like effects of essential oil and asarone, a major essential oil component from the rhizome of Acorus tatarinowii", Pharm Biol, 51(5), pp.589~594 (2013)
55. Chellian R, "Biphasic effects of α-asarone on immobility in the tail suspension test : evidence for the involvement of the noradrenergic and serotonergic systems in its antidepressant-like activity", Front Pharmacol, 7, pp.72~ (2016)
56. Liu S, "Anxiolytic-like effect of α-asarone in mice", Phytother Res, 26(10), pp.1476~1481 (2012)
57. Radhakrishnan A, "α-Asarone in management of sleep deprivation induced memory deficits and anxiety in rat model", Sleep Biol Rhythms, 17(1), pp.37~47 (2019)
58. Tian J, "Anxiolytic-like effects of α-asarone in a mouse model of chronic pain", Metab Brain Dis, 32(6), pp.2119~2129 (2017)
59. 이봄비, "Alpha-Asarone, a Major Component of Acorus gramineus, Attenuates Corticosterone-Induced Anxiety-Like Behaviours via Modulating TrkB Signaling Process", The Korean Journal of Physiology & Pharmacology, 18(3), pp.191~200 (2014), 대한약리학회
60. Chang BS, "Epilepsy", N Engl J Med, 349(13), pp.1257~1266 (2003)
61. Miao JK, "Antiepileptic properties of alpha-asarone from acori graminei rhizoma in mice and rats seizure models", Int J Pharmacol, 8(6), pp.567~571 (2012)
62. Chen QX, "Anticonvulsant activity of acute and chronic treatment with a-asarone from Acorus gramineus in seizure models", Biol Pharm Bull, 36(1), pp.23~30 (2013)
63. Liao WP, "Study of antiepileptic effect of extracts from Acorus tatarinowii Schott", Epilepsia, 46(Suppl 1), pp.21~24 (2005)
64. Liao JF, "Central inhibitory effects of water extract of Acori graminei rhizoma in mice", J Ethnopharmacol, 61(3), pp.185~193 (1998)
65. Koo BS, "Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system", Biol Pharm Bull, 26(7), pp.978~982 (2003)
66. Cho J, "NMDA recepter-mediated neuroprotection by essential oils from the rhizomes of Acorus gramineus", Life Sci, 68(13), pp.1567~1573 (2001)
67. Huang C, "α-asarone from Acorus gramineus alleviates epilepsy by modulating A-type GABA receptors", Neuropharmacology, 65, pp.1~11 (2013)
68. Chellian R, "Protective effect of α-asarone against nicotine-induced seizures in mice, but not by its interaction with nicotinic acetylcholine receptors", Biomed Pharmacother, 108, pp.1591~1595 (2018)
69. Miao JK, "Modulation effects of α-asarone on the GABA homeostasis in the lithiumpilocarpine model of temporal lobe epilepsy", Int J Pharmacol, 9(1), pp.24~32 (2013)
70. Wang ZJ, "Identification of both GABAA receptors and voltage-activated Na(+) channels as molecular targets of anticonvulsant α-asarone", Front Pharmacol, 5, pp.40~ (2014)
71. Pages N, "Activities of α-asarone in various animal seizure models and in biochemical assays might be essentially accounted for by antioxidant properties", Neurosci Res, 68(4), pp.337~344 (2010)
72. Liu HJ, "α-Asarone attenuates cognitive deficit in a pilocarpine-induced status epilepticus rat model via a decrease in the nuclear factor-κB activation and reduction in microglia neuroinflammation", Front Neurol, 8, pp.661~ (2017)
73. Donnan GA, "Stroke", Lancet, 371(9624), pp.1612~1623 (2008)
74. Mo ZT, "β-Asarone protects PC12 cells against OGD", R-induced injury via attenuating Beclin-1-dependent autophagy, 2012, pp.33(6), 737~742
75. Liu L, "Beta-asarone attenuates ischemia-reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1", Eur J Pharmacol, 680(1-3), pp.34~40 (2012)
76. Zhang K, "Neuroprotective effect of alpha-asarone on the rats model of cerebral ischemia-reperfusion stroke via ameliorating glial activation and autophagy", Neuroscience, 473, pp.130~141 (2021)
77. Yang F, "β-Asarone protects PC12 cells against hypoxia-induced injury via negatively regulating RPPH1", MiR-542-3p, Cell Transplant, pp.2022, 31[DOI]
78. Young Ock Kim, "Effects of α-Asarone against Global Cerebral Ischemia in Rats", Natural Product Sciences, 15(4), pp.198~202 (2009), 한국생약학회
79. Pan H, "Effects of β-asarone on ischemic stroke in middle cerebral artery occlusion rats by an Nrf2-antioxidant response elements (ARE) pathway-dependent mechanism", Med Sci Monit, 27, pp.e931884~ (2021)
80. Yang YX, "Beta-asarone, a major component of Acorus tatarinowii Schott, attenuates focal cerebral ischemia induced by middle cerebral artery occlusion in rats", BMC Complement Altern Med, 13, pp.236~ (2013)
81. Lim HW, "β-Asarone(cis-2, 4, 5-trimethoxy-1-allyl phenyl), attenuates proinflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells", Food Chem Toxicol, 72, pp.265~272 (2014)
82. Lee YC, "Acorus tatarinowii Schott extract reduces cerebral edema caused by ischemia-reperfusion injury in rats : involvement in regulation of astrocytic NKCC1", AQP4 and JNK, BMC Complement Med Ther, pp.2020, 20(1)[DOI]
83. Lee HJ, "Positive effects of α-asarone on transplanted neural progenitor cells in a murine model of ischemic stroke", Phytomedicine, 51, pp.151~161 (2018)
84. Dang H, "Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress", Exp Biol Med (Maywood), 234(7), pp.785~793 (2009)
85. Zhang B, "Postsynaptic GluR2 involved in amelioration of Aβ-induced memory dysfunction by KAIXIN-San through rescuing hippocampal LTP in mice", Rejuvenation Res, 22(2), pp.131~137 (2019)
86. Yu S, "Novel insights into antidepressant mechanism of Kai Xin San formula: inhibiting NLRP3 inflammasome activation by promoting autophagy", Phytomedicine, 93, pp.153792~ (2021)
87. Li X, "Mitochondrial protection and against glutamate neurotoxicity via Shh", Ptch1signaling pathway to ameliorate cognitive dysfunction by Kaixin San in multi-infarct dementia rats, 2021, pp.2021, 5590745~
88. Xu YM, "Kai Xin San ameliorates scopolamine-induced cognitive dysfunction", Neural Regen Res, 14(5), pp.794~804 (2019)
89. Huang YL, "Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression", Chin J Integr Med, 21(7), pp.507~515 (2015)
90. Wang N, "Neuroprotective mechanism of Kai Xin San : upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation", Neural Regen Res, 12(4), pp.654~659 (2017)
91. Huang SJ, "Effects of Kaixin Jieyu Decoction (开心解郁汤) on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model", Chin J Integr Med, 20(4), pp.280~285 (2014)
92. Zhang XH, "Effects of kaixin jieyu decoction on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model", Chin J Integr Med, 21(3), pp.223~228 (2015)
93. Xiong W, "Qisheng Wan formula ameliorates cognitive impairment of Alzheimer’s disease rat via inflammation inhibition and intestinal microbiota regulation", J Ethnopharmacol, 282, pp.114598~ (2022)
94. Hui S, "Protective effects of Bushen Tiansui decoction on hippocampal synapses in a rat model of Alzheimer’s disease", Neural Regen Res, 12(10), pp.1680~1686 (2017)
95. Huang Q, "Chinese herbal extracts exert neuroprotective effect in Alzheimer’s disease mouse through the dopaminergic synapse", apoptosis signaling pathway, 2022, pp.13, 817213~
96. Peng A, "Bazhu decoction, a traditional Chinese medical formula, ameliorates cognitive deficits in the 5xFAD mouse model of Alzheimer’s disease", Front Pharmacol, 10, pp.1391~ (2019)
97. Lee MR, "Antiamnesic effect of Chong-Myung-Tang on scopolamine-induced memory impairments in mice", J Ethnopharmacol, 132(1), pp.70~74 (2010)
98. Lin C, "Changes of brain activity during a functional magnetic resonance imaging stroop task study : effect of Chinese herbal formula in Alzheimer’s disease", Eur J Integr Med, 16, pp.46~53 (2017)
99. Bae N, "The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson’s disease", J Ethnopharmacol, 134(2), pp.313~322 (2011)

관련 논문AI추천